TY - JOUR
T1 - Comprehensive Molecular Characterization of Polymorphous Adenocarcinoma, Cribriform Subtype
T2 - Identifying Novel Fusions and Fusion Partners
AU - Hahn, Elan
AU - Xu, Bin
AU - Katabi, Nora
AU - Dogan, Snjezana
AU - Smith, Stephen M.
AU - Perez-Ordonez, Bayardo
AU - Patel, Paras B.
AU - MacMillan, Christina
AU - Lubin, Daniel J.
AU - Gagan, Jeffrey
AU - Weinreb, Ilan
AU - Bishop, Justin A.
N1 - Publisher Copyright:
© 2023 United States & Canadian Academy of Pathology
PY - 2023/11
Y1 - 2023/11
N2 - Polymorphous adenocarcinoma (PAC) is a common, usually low-grade salivary gland carcinoma. While conventional PACs are most associated with PRKD1 p.E710D hotspot mutations, the cribriform subtype is often associated with gene fusions in PRKD1, PRKD2, or PRKD3. These fusions have been primarily identified by fluorescence in situ hybridization (FISH) analysis, with a minority evaluated by next-generation sequencing (NGS). Many of the reported fusions were detected by break-apart FISH probes and therefore have unknown partners or were negative by FISH altogether. In this study, we aimed to further characterize the fusions associated with PAC with NGS. Fifty-four PACs (exclusively cribriform and mixed/intermediate types to enrich the study for fusion-positive cases) were identified and subjected to NGS. Fifty-one cases were successfully sequenced, 28 of which demonstrated gene fusions involving PRKD1, PRKD2, or PRKD3. There were 10 cases with the PRKD1 p.E710D mutation. We identified a diverse group of fusion partners, including 13 novel partners, 3 of which were recurrent. The most common partners for the PRKD genes were ARID1A and ARID1B. The wide variety of involved genes is unlike in other salivary gland malignancies and warrants a broader strategy of sequencing for molecular confirmation for particularly challenging cases, as our NGS study shows.
AB - Polymorphous adenocarcinoma (PAC) is a common, usually low-grade salivary gland carcinoma. While conventional PACs are most associated with PRKD1 p.E710D hotspot mutations, the cribriform subtype is often associated with gene fusions in PRKD1, PRKD2, or PRKD3. These fusions have been primarily identified by fluorescence in situ hybridization (FISH) analysis, with a minority evaluated by next-generation sequencing (NGS). Many of the reported fusions were detected by break-apart FISH probes and therefore have unknown partners or were negative by FISH altogether. In this study, we aimed to further characterize the fusions associated with PAC with NGS. Fifty-four PACs (exclusively cribriform and mixed/intermediate types to enrich the study for fusion-positive cases) were identified and subjected to NGS. Fifty-one cases were successfully sequenced, 28 of which demonstrated gene fusions involving PRKD1, PRKD2, or PRKD3. There were 10 cases with the PRKD1 p.E710D mutation. We identified a diverse group of fusion partners, including 13 novel partners, 3 of which were recurrent. The most common partners for the PRKD genes were ARID1A and ARID1B. The wide variety of involved genes is unlike in other salivary gland malignancies and warrants a broader strategy of sequencing for molecular confirmation for particularly challenging cases, as our NGS study shows.
KW - PRKD
KW - cribriform
KW - gene fusions
KW - head and neck pathology
KW - molecular pathology
KW - polymorphous adenocarcinoma
KW - salivary gland tumors
UR - http://www.scopus.com/inward/record.url?scp=85177498259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85177498259&partnerID=8YFLogxK
U2 - 10.1016/j.modpat.2023.100305
DO - 10.1016/j.modpat.2023.100305
M3 - Article
C2 - 37595638
AN - SCOPUS:85177498259
SN - 0893-3952
VL - 36
JO - Modern Pathology
JF - Modern Pathology
IS - 11
M1 - 100305
ER -